BARD PHARMACEUTICALS LIMITED
Get an alert when BARD PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1K
Latest balance sheet
Net assets
£67M
Equity attributable
Employees
353
Average over period
Profit before tax
£7.3M
Period ending 2024-12-31
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £104,247,000 | £93,184,000 | — | |
| Operating profit | £7,315,000 | £7,282,000 | — | |
| Profit before tax | £7,363,000 | £7,285,000 | — | |
| Net profit | £5,661,000 | £5,525,000 | — | |
| Cash | £75,000 | £1,000 | — | |
| Total assets less current liabilities | £67,288,000 | £74,424,000 | — | |
| Net assets | £61,408,000 | £66,962,000 | — | |
| Equity | £61,408,000 | £66,962,000 | — | |
| Average employees | 361 | 353 | — | |
| Wages | £19,913,000 | £19,468,000 | — | |
| Directors' remuneration | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. Year-on-year comparison hidden: this filing's period length differs materially from the prior year. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 7.0% | 7.8% | |
| Net margin | 5.4% | 5.9% | |
| Return on capital employed | 10.9% | 9.8% | |
| Current ratio | 1.50x | 1.59x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on this assessment the directors continue to adopt the going concern basis in preparing the annual report and accounts. In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Significant events
- “Capital expenditure has increased by £5,202,000 (75%) compared to the comparative figures for 2023. This is due to the ongoing investment program to expand the existing Good Manufacturing Practice (GMP) filling and packaging area, replacing obsolete equipment & control systems and modernising the IT systems used in the manufacturing operation.”
- “On 16 June 2023, a UK High Court judgment in the case of Virgin Media Ltd v NTL Pension Trustees II Ltd raised questions regarding the validity of certain amendments made to contracted-out defined benefit (DB) pension schemes between 1997 and 2016. In July 2024, the Court of Appeal dismissed the appeal brought by Virgin Media Ltd against aspects of the June 2023 decision.”
- “The Company's pension scheme was contracted out during this period and made amendments that may have affected members' benefits. A legal review in 2024 concluded that all significant amendments made between 1997 and 2016 were accompanied by the necessary actuarial confirmation.”
- “On 5 June 2025, the Department for Work and Pensions announced it will introduce legislation to allow defined benefit pensions schemes to obtain retrospective sign-off on historic actuarial amendments. The industry is awaiting the details of this legislation and the outcome of a secondary High Court case to clarify what next steps are required.”
- “There have been no subsequent events affecting the Company since the year end.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JAMIESON, Stephen Johan | Director | 2019-02-22 | Sep 1957 | British |
| LEA, Bryan George | Director | 2020-01-01 | Jun 1961 | British |
| VARSHNEY, Ajay | Director | 2024-06-14 | May 1974 | Indian |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORNHILL SERVICES LIMITED | Corporate Secretary | 2008-03-25 | 2009-02-26 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | 2009-02-26 | 2018-06-11 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | — | 2008-03-25 |
| BAKER, Stuart David | Director | 2017-08-08 | 2019-12-31 |
| BRADLEY, Dominic Michael, Dr | Director | 2023-02-03 | 2024-12-13 |
| BROGDEN, John Robert | Director | — | 2005-03-30 |
| CHAPLIN, John Richard | Director | — | 1999-09-09 |
| CLARKE, Robert Alan | Director | 2012-11-07 | 2015-12-31 |
| GOFF, Valerie May | Director | 1999-01-31 | 2015-12-31 |
| LESLIE, Stewart T | Director | — | 1997-12-31 |
| MANNERS, Paul | Director | — | 2001-12-31 |
| MATTESSICH, Antony Charles | Director | 2005-04-01 | 2017-07-31 |
| MITCHELL, Christopher Benbow | Director | — | 2018-04-12 |
| MOODY, Colm Joseph | Director | 2015-04-01 | 2022-06-30 |
| NICOL, Eric Gordan | Director | — | 1999-12-31 |
| WIKSTROM, Ake Gunnar | Director | 2018-04-12 | 2019-02-22 |
| WIKSTROM, Ake Gunnar | Director | 2001-09-05 | 2011-05-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Napp Pharmaceutical Group Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 168 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-17 | CH01 | officers | Change person director company with change date | |
| 2025-09-09 | AA | accounts | Accounts with accounts type full | |
| 2025-05-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-06 | AD02 | address | Change sail address company with old address new address | |
| 2024-12-13 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-12 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-08-27 | AA | accounts | Accounts with accounts type full | |
| 2024-06-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-14 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-04 | CH01 | officers | Change person director company with change date | |
| 2023-10-12 | AA | accounts | Accounts with accounts type full | |
| 2023-06-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-13 | AP01 | officers | Appoint person director company with name date | |
| 2022-12-14 | AA | accounts | Accounts with accounts type full | |
| 2022-07-26 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-07-04 | CH01 | officers | Change person director company with change date | |
| 2022-07-04 | TM01 | officers | Termination director company with name termination date | |
| 2022-06-22 | AD02 | address | Change sail address company with old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.